BTL Industries v. Your Sculpt Studio: Voluntary Dismissal in Body Contouring Patent Dispute
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | BTL Industries, Inc. v. Your Sculpt Studio, LLC |
| Case Number | 1:25-cv-00945 (D.D.C.) |
| Court | U.S. District Court for the District of Columbia |
| Duration | Mar 2025 – Oct 2025 191 days |
| Outcome | Voluntary Dismissal (Without Prejudice) |
| Patents at Issue | |
| Accused Products | EmSlim, EmSlim NEO, Emslim Classic, Total Tone, TotalTone (and related services) |
When BTL Industries, Inc. filed its patent infringement complaint against Your Sculpt Studio, LLC on March 31, 2025, the case appeared poised to test the boundaries of electromagnetic muscle stimulation technology patents in the competitive body contouring market. Instead, after 191 days of litigation in the U.S. District Court for the District of Columbia, BTL Industries elected to voluntarily dismiss the complaint — without prejudice — before the case reached adjudication on the merits.
Case No. 1:25-cv-00945, presided over by Chief Judge Richard J. Leon, centered on two issued U.S. patents covering EmSlim and related electromagnetic body contouring devices and alleged infringement by Your Sculpt Studio’s competing aesthetic treatment offerings. The voluntary dismissal without prejudice preserves BTL’s legal options and raises important strategic questions for patent holders, accused infringers, and R&D teams operating in the rapidly expanding medical aesthetics technology space. For patent litigators and IP professionals, this case offers a measured but instructive lens into pre-trial litigation dynamics, enforcement strategy, and the calculated use of voluntary dismissal as a procedural tool.
Case Overview
The Parties
⚖️ Plaintiff
Established medical device and aesthetics technology company, recognized for EmSculpt and EmSlim product lines (HIFEM technology). Active enforcer of IP rights.
🛡️ Defendant
Aesthetic services provider offering body contouring treatments, named as defendant for alleged use of infringing products.
Patents at Issue
This case involved two issued U.S. patents covering electromagnetic muscle stimulation technology, central to BTL’s competitive position in body contouring:
- • U.S. Patent No. 10,478,634 B2 — directed to electromagnetic body treatment technology
- • U.S. Patent No. 11,679,255 B2 — directed to further developments in electromagnetic muscle stimulation systems
Developing a similar medical device?
Check if your body contouring technology might infringe these or related patents.
The Verdict & Legal Analysis
Outcome
BTL Industries filed a notice of voluntary dismissal pursuant to Rule 41(a) of the Federal Rules of Civil Procedure, requesting that the Court enter an order dismissing the complaint without prejudice. The Court granted the dismissal accordingly. No damages were awarded, and no injunctive relief was issued.
Specific financial terms or settlement consideration, if any existed informally, were not disclosed in the public case record.
Key Legal Issues
The official verdict cause is recorded as an Infringement Action, with the basis of termination being voluntary dismissal. Because the case was dismissed before any substantive rulings on validity, claim construction, or infringement, there is no judicial analysis of the merits available from this proceeding.
Voluntary dismissal without prejudice under Rule 41(a) signals several potential strategic realities: negotiated resolution, plaintiff’s reassessment of litigation value, or defendant’s compliance or exit from the market. The “without prejudice” designation is legally significant: BTL retains the right to refile the same claims should circumstances warrant, preserving its enforcement leverage.
While this case produced no precedential rulings, its structure reflects important doctrinal considerations in electromagnetic body contouring patent litigation:
- Patent Nos. 10,478,634 and 11,679,255 remain fully enforceable and unchallenged by any IPR petition or invalidity finding arising from this matter.
- BTL’s willingness to file and then dismiss without prejudice reinforces its posture as an active patent enforcer willing to initiate litigation — which itself carries deterrent value across the industry.
- The case underscores the enforceability risk for downstream service providers (studios, clinics) that use third-party devices without confirming those devices’ freedom to operate under dominant patent portfolios.
Filing a patent for your medical device?
Learn from this case. Use AI to draft stronger claims that can withstand litigation.
Power Your Patent Strategy with Eureka IP
From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in the body contouring device market. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation for electromagnetic body contouring technology.
- View the 2 asserted patents in this technology space
- See which companies are most active in electromagnetic aesthetics patents
- Understand BTL’s enforcement patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product in the medical aesthetics space.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Electromagnetic muscle stimulation (HIFEM) technology
2 Asserted Patents
Covering core HIFEM architecture
Design-Around Options
Possible with strategic FTO analysis
✅ Key Takeaways
For Patent Attorneys & Litigators
Voluntary dismissal without prejudice preserves the plaintiff’s right to refile — treat it as a strategic pause, not a concession.
Search related case law →Both patents-in-suit (US 10,478,634 B2 and US 11,679,255 B2) remain valid, enforceable, and unchallenged by this proceeding.
Explore these patents →For R&D Teams & IP Professionals
Any electromagnetic muscle stimulation product entering the aesthetics market must clear a thorough FTO review against BTL’s patent portfolio before commercialization.
Start FTO analysis for my product →Downstream service providers (studios, clinics) should demand FTO representations from device suppliers as a contractual matter to mitigate infringement risk.
Learn about IP risk management →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.